Clinical trial
A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in…
NCT05389319 · University Hospital Tuebingen, Other · Suspended
Key facts
| NCT number | NCT05389319 |
|---|---|
| Title | A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults |
| Official title | A Phase Ia, Dose-finding Study to Assess the Safety and Immunogenicity of an Orf Virus-based COVID-19 Vaccine Booster (Prime-2-CoV_Beta) in Healthy Adults |
| Lead sponsor | University Hospital Tuebingen, Other |
| Collaborators | FGK Clinical Research GmbH Industry VisMederi srl Staburo GmbH Viedoc Technologies AB |
| Status | Suspended |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | COVID-19 |
| Intervention type | Biological |
| Interventions | Prime-2-CoV_Beta |
| Enrollment | 60 |
| Start date | Jun 24, 2022 |
| Primary completion | Aug 31, 2027 |
| Completion | Aug 31, 2028 |
| First posted | May 25, 2022 |
| Last update posted | Mar 30, 2025 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: